- Reference code :
- wf5262
- Published date :
-
27 July 2006
- Expired date :
-
12 December 2033
"A strong second quarter, with sales up 10 percent and Earnings per Share up 41 percent; on track to achieve financial targets for the full year."
Download the narrative and the figures
Download the narrative
and the figures
.
Media Enquiries:
Steve Brown/Edel McCaffrey (London) (020) 7304 5033/5034
Staffan Ternby (Södertälje) (8) 553 26107
Carla Burigatto (Wilmington) (302) 886 5953
Analyst/Investor Enquiries:
Mina Blair/ Jonathan Hunt (London) (020) 7304 5084/5087
Staffan Ternby (Södertälje) (8) 553 26107
Ed Seage/Jörgen Winroth (USA) (302) 886 4065/(212) 579 0506
Download the narrative
and the figures
.Further enquiries to:
Media Enquiries:
Steve Brown/Edel McCaffrey (London) (020) 7304 5033/5034
Staffan Ternby (Södertälje) (8) 553 26107
Carla Burigatto (Wilmington) (302) 886 5953
Analyst/Investor Enquiries:
Mina Blair/ Jonathan Hunt (London) (020) 7304 5084/5087
Staffan Ternby (Södertälje) (8) 553 26107
Ed Seage/Jörgen Winroth (USA) (302) 886 4065/(212) 579 0506
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
